Skip to main content

Advertisement

SpringerLink
Log in

Proton pump inhibitors reduce gallbladder function

  • Published:
Surgical Endoscopy And Other Interventional Techniques Aims and scope Submit manuscript

Abstract

Background

In the authors’ previous study of gallbladder function before and after fundoplication, 58% of the patients demonstrated preoperative gallbladder motor dysfunction, and 86% of those retested after operation and cessation of proton pump inhibitors (PPIs) normalized. Because no study has directly assessed the impact of antisecretory agents on gallbladder function, this study measured gallbladder ejection fraction (GBEF) in healthy volunteers before and after initiation of PPIs.

Methods

A total of 19 subjects completed the study, which included baseline determination of GBEF by cholecystokinin-stimulated hepatobiliary acid scan, 30 days of antisecretory therapy with omeprazole (40 mg daily), and repeat GBEF on day 30. Subjects were surveyed regarding compliance and symptoms.

Results

For 15 of 19 subjects, PPI therapy was associated with reduced gallbladder motility. Evolution of symptoms consistent with a biliary etiology was reported by 26.7% of these subjects.

Conclusions

Short-term PPI therapy reduces gallbladder motility in healthy volunteers. Chronic PPI therapy may pose a risk for long-term gallbladder dysfunction and biliary complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ (2001) No association between gallstones and gastroesophageal reflux disease. Am J Gastroenterol 96: 2858–2862

    Article  PubMed  CAS  Google Scholar 

  2. Bardhan KD (1999) Pantoprazole: a new proton pump inhibitor in the management of upper gastrointestinal disease. Drugs Today (Barc) 35: 773–808

    CAS  Google Scholar 

  3. Bucceri AM, Calogero AE, Brogna A (2002) Gallbladder and gastric emptying: relationship to cholecystokininemia in diabetics. Eur J Intern Med 13: 123–128

    Article  PubMed  CAS  Google Scholar 

  4. Cadiot G, Vissuzaine C, Pospai D, Ruszniewski P, Potet F, Mignon M (1995) Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa: preliminary results. Gastroenterol Clin Biol 19: 811–817

    PubMed  CAS  Google Scholar 

  5. Capron JP, Payenneville H, Dumont M, Dupas JL, Lorriaux A (1978) Evidence for an association between cholelithiasis and hiatus hernia. Lancet 2: 329–331

    PubMed  CAS  Google Scholar 

  6. Cattey RP, Wilson SD (1989) Cholelithiasis follows total gastrectomy in Zollinger-Ellison syndrome. Surgery 106: 1070–1073

    PubMed  CAS  Google Scholar 

  7. Chowdhury JR, Berkowitz JM, Praissman M, Fara JW (1975) Interaction between octapeptide-cholecystokinin, gastrin, and secretin on cat gallbladder in vitro. Am J Physiol; 229: 1311–1315

    PubMed  CAS  Google Scholar 

  8. Chowdhury JR, Berkowitz JM, Praissman M, Fara JW (1976) Effect of sulfated and nonsulfated gastrin and octapeptide-cholecystokinin on cat gall bladder in vitro. Experientia 32: 1173–1175

    Article  PubMed  CAS  Google Scholar 

  9. DiBaise JK, Oleynikov D (2003) Does gallbladder ejection fraction predict outcome after cholecystectomy for suspected chronic acalculous gallbladder dysfunction? A systematic review. Am J Gastroenterol 98: 2605–2611

    Article  PubMed  Google Scholar 

  10. Festen HP, Thijs JC, Lamers CB, Jansen JM, Pals G, Frants RR, Defize J, Meuwissen SG (1984) Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 87: 1030–1034

    PubMed  CAS  Google Scholar 

  11. Gallup Organization (1988) A Gallup Organization National Survey: Heartburn Across America. Gallup Organization, Princeton, NJ

    Google Scholar 

  12. Grider JR, Makhlouf GM (1990) Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am J Physiol 259: G184–G190

    PubMed  CAS  Google Scholar 

  13. Koop H, Klein M, Arnold R (1990) Serum gastrin levels during long-term omeprazole treatment. Aliment Pharm Ther 4: 131–138

    Article  CAS  Google Scholar 

  14. Krishnamurthy GT, Krishnamurthy S, Brown PH (2004) Constancy and variability of gallbladder ejection fraction: impact on diagnosis and therapy. J Nucl Med 45: 1872–1877

    PubMed  Google Scholar 

  15. Krishnamurthy S, Krishnamurthy GT (1997) Biliary dyskinesia: role of the sphincter of Oddi, gallbladder, and cholecystokinin. J Nucl Med 38: 1824–1830

    PubMed  CAS  Google Scholar 

  16. Manifold DK, Anggiansah A, Owen WJ (2000) Effect of cholecystectomy on gastroesophageal and duodenogastric reflux. Am J Gastroenterol 95: 2746–2750

    PubMed  CAS  Google Scholar 

  17. Morton JM, Bowers SP, Lucktong TA, Mattar S, Bradshaw WA, Behrns KE, Koruda MJ, Herbst CA, McCartney W, Halkar RK, Smith CD, Farrell TM (2002) Gallbladder function before and after fundoplication. J Gastrointest Surg 6: 806–810

    Article  PubMed  Google Scholar 

  18. Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H (2004) Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with Helicobacter pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Hepatogastroenterology 51: 338–342

    PubMed  Google Scholar 

  19. Portincasa P, Di Ciaula A, Palmieri V, Velardi A, VanBerge-Henegouwen GP, Palasciano G (1997) Impaired gallbladder and gastric motility and pathological gastro-oesophageal reflux in gallstone patients. Eur J Clin Invest 27: 653–661

    Article  PubMed  CAS  Google Scholar 

  20. Rasmussen L, Oster-Jorgensen E, Qvist N, Hovendal CP, Kraglund K, Olsen O, Schaffalitzky de Muckadell OB, Rehfeld J, Pedersen SA (1992) The effects of omeprazole on interdigestive motility and early postprandial levels of gastrin and secretin. Scan J Gastroenterol 27: 119–123

    Article  CAS  Google Scholar 

  21. Rasmussen L, Qvist N, Oster-Jorgensen E, Rehfeld JF, Holst JJ, Pedersen SA (1997) A double-blind placebo-controlled study of the effects of omeprazole on gut hormone secretion and gastric emptying rate. Scand J Gastroenterol 32: 900–905

    PubMed  CAS  Google Scholar 

  22. Ryan J, Cohen S (1976) Gallbladder pressure–volume response to gastrointestinal hormones. Am J Physiol 230: 1461–1465

    PubMed  CAS  Google Scholar 

  23. Schjoldager BT (1994) Role of CCK in gallbladder function. Ann NY Acad Sci 713: 207–218

    PubMed  CAS  Google Scholar 

  24. Toouli J, Hogan WJ, Geenen JE, Dodds WJ, Arndorfer RC (1982) Action of cholecystokinin octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans. Surgery 92: 497–503

    PubMed  CAS  Google Scholar 

  25. Vaczek D (2003) Top 200 drugs of 2002. Pharm Times, April p 20

  26. Valenzuela JE, Walsh JH, Isenberg JI (1976) Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man. Gastroenterology 71: 409–411

    PubMed  CAS  Google Scholar 

  27. Watson S, Arkinstall S (1994) Cholecystokinin (CCK) and gastrin. In: Watson S, Arkinstall S (eds) The G Protein-Linked Receptor Factsbook. Academic Press, London pp 89–95

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of North Carolina at Chapel Hill, Campus Box 7081, Chapel Hill, North Carolina, 27599-7081, USA

    M. A. Cahan, L. Balduf, K. Colton, B. Palacioz & T. M. Farrell

  2. Department of Radiology, University of North Carolina at Chapel Hill, Campus Box 7081, North Carolina, 27599-7081, USA

    W. McCartney

Authors
  1. M. A. Cahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Balduf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Colton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Palacioz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. McCartney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. M. Farrell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. M. Farrell.

Additional information

Dr. Cahan currently is affiliated with the Department of Surgery at the University of Massachusetts, Worcester, MA, USA

Presented at the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) meeting in Fort Lauderdale, Florida 15 April 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cahan, M.A., Balduf, L., Colton, K. et al. Proton pump inhibitors reduce gallbladder function. Surg Endosc 20, 1364–1367 (2006). https://doi.org/10.1007/s00464-005-0247-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-005-0247-x

Keywords

Search

Navigation